Literature DB >> 12110753

Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.

Carmine M Pariante, Sabine Landau, Bernardo Carpiniello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12110753     DOI： 10.1056/NEJM200207113470221

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

2.  The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.

Authors:  Tarek Hassanein; Mitchell L Shiffman; Nizar N Zein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

Review 3.  Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.

Authors:  Jennifer M Loftis; Annette M Matthews; Peter Hauser
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.

Authors:  S J Bull; P Huezo-Diaz; E B Binder; J F Cubells; G Ranjith; C Maddock; C Miyazaki; N Alexander; M Hotopf; A J Cleare; S Norris; E Cassidy; K J Aitchison; A H Miller; C M Pariante
Journal:  Mol Psychiatry       Date:  2008-05-06       Impact factor: 15.992

5.  Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.

Authors:  Robert J Fontana; Ziad Kronfol; Karen L Lindsay; Linas A Bieliauskas; Latha Padmanabhan; Carla Back-Madruga; Anna S F Lok; Anne M Stoddard
Journal:  Am J Gastroenterol       Date:  2008-08-21       Impact factor: 10.864

6.  Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels.

Authors:  Kuan-Pin Su; Shih-Yi Huang; Cheng-Yuan Peng; Hsueh-Chou Lai; Chieh-Liang Huang; Yi-Chih Chen; Katherine J Aitchison; Carmine M Pariante
Journal:  Biol Psychiatry       Date:  2009-12-24       Impact factor: 13.382

7.  Comparison of the prevalence of psychiatric co-morbidities in hepatitis C patients and hepatitis B patients in Saudi Arabia.

Authors:  Yaser R AlHuthail
Journal:  Saudi J Gastroenterol       Date:  2013 Jul-Aug       Impact factor: 2.485
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.